RS3935209 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (11)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| 5-oxoproline levels | G | OR: 0.82 | 3E-220 | PubMed |
| 6-oxopiperidine-2-carboxylic acid levels | T | OR: 0.48 | 6E-150 | PubMed |
| Metabolite levels (5-oxoproline; pyroglutamic_acid) | G | OR: 0.51 | 3E-122 | PubMed |
| Metabolite levels (6-oxopiperidine-2-carboxylic acid; 6-oxopiperidine-2-carboxylate) | G | OR: 0.54 | 2E-102 | PubMed |
| Serum metabolite levels | T | OR: 0.72 | 4E-100 | PubMed |
| Plasma 5-oxoproline levels in chronic kidney disease | G | OR: 0.22 | 2E-83 | PubMed |
| 5-oxoproline levels | T | OR: 0.34 | 9E-76 | PubMed |
| 6-oxopiperidine-2-carboxylate levels | G | OR: 0.64 | 2E-68 | PubMed |
| Pyroglutamic acid levels | G | OR: 0.42 | 1E-53 | PubMed |
| Plasma 6-oxopiperidine-2-carboxylate levels in chronic kidney disease | G | OR: 0.22 | 8E-26 | PubMed |
| Cerebrospinal fluid 5-oxoproline levels | T | β: 0.037 | 2E-24 | PubMed |